The integration of early palliative care with oncology care: The time has come for a new tradition

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 12, 2014, Pages 1763-1771

  Bauman, Jessica R ^a   Temel, Jennifer S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTINUING EDUCATION; EARLY INTERVENTION; HUMAN; INTEGRATIVE MEDICINE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); NEOPLASMS; PALLIATIVE THERAPY; PATHOLOGY; PROGNOSIS;

HUMANS; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; QUALITY OF LIFE;

EID: 84918811197     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0177     Document Type: Article

References (50)

1. Cheung WY, Le LW, Zimmermann C. Symptom clusters in patients with advanced cancers. Support Care Cancer 2009; 17: 1223-1230.
2. Greer JA, Jackson VA, Meier DE, Temel JS. Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 2013; 63: 349-363.
3. El-Jawahri A, Greer JA, Temel JS. Does palliative care improve outcomes for patients with incurable illness? A review of the evidence. J Support Oncol 2011; 9: 87-94.
4. Gilbertson-White S, Aouizerat BE, Jahan T, Miaskowski C. A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliat Support Care 2011; 9: 81-102.
5. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-Analysis of 94 interview-based studies. Lancet Oncol 2011; 12: 160-174.
6. Welslau M, Dieras V, Sohn JH, et al. Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer. Cancer 2014; 120: 642-651.
7. Cella D, Herbst RS, Lynch TJ, et al. Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial. J Clin Oncol 2005; 23: 2946-2954.
8. Cadranel J, Zalcman G, Sequist L. Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer. Eur Respir J 2011; 37: 183-193.
9. Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 2013; 368: 2385-2394.
10. Pirl WF, Muriel A, Hwang V, et al. Screening for psychosocial distress: A national survey of oncologists. J Support Oncol 2007; 5: 499-504.
11. Breuer B, Fleishman SB, Cruciani RA, Portenoy RK. Medical oncologists' attitudes and practice in cancer pain management: A national survey. J Clin Oncol 2011; 29: 4769-4775.
12. Von Roenn JH, Voltz R, Serrie A. Barriers and approaches to the successful integration of palliative care and oncology practice. J Natl Compr Canc Netw 2013; 11(Suppl 1): S11-16.
13. Bukki J, Scherbel J, Stiel S, et al. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: A retrospective chart review. Support Care Cancer 2013; 21: 1743-1750.
14. Morden NE, Chang CH, Jacobson JO, et al. End-of-life care for Medicare beneficiaries with cancer is highly intensive overall and varies widely. Health Aff (Millwood) 2012; 31: 786-796.
15. Ahmad S, O'Mahony MS. Where older people die: A retrospective population-based study. QJM 2005; 98: 865-870.
16. Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004; 22: 315-321.
17. Temel JS, McCannon J, Greer JA, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer 2008; 113: 826-833.
18. Behl D, Jatoi A. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med 2010; 13: 831-835.
19. Gruneir A, Mor V, Weitzen S, et al. Where people die: A multilevel approach to understanding influences on site of death in America. Med Care Res Rev 2007; 64: 351-378.
20. National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliaitve Care, Third Edition. Available at: Http://www.nationalconsensusproject.org/NCP-Clinical-Practice-Guidelines-3rd-Edition.pdf. Accessed July 23, 2014.
21. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: The Project ENABLE II randomized controlled trial. JAMA 2009; 302: 741-749.
22. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
23. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial. Lancet 2014; 383: 1721-1730.
24. Cancer. WHO Definition of Palliative Care. World Health Organization Web site. Available at: Http://www.who.int/cancer/palliative/definition/en/. Accessed July 5, 2014.
25. Reville B, Miller MN, Toner RW, Reifsnyder J. End-of-life care for hospitalized patients with lung cancer: Utilization of a palliative care service. J Palliat Med 2010; 13: 1261-1266.
26. Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol 2012; 30: 4380-4386.
27. Smith CB, Nelson JE, Berman AR, et al. Lung cancer physicians' referral practices for palliative care consultation. Ann Oncol 2012; 23: 382-387.
28. Gelfman LP, Meier DE, Morrison RS. Does palliative care improve quality? A survey of bereaved family members. J Pain Symptom Manage 2008; 36: 22-28.
29. Brumley R, Enguidanos S, Jamison P, et al. Increased satisfaction with care and lower costs: Results of a randomized trial of in-home palliative care. J Am Geriatr Soc 2007; 55: 993-1000.
30. Zimmermann C, Riechelmann R, Krzyzanowska M, et al. Effectiveness of specialized palliative care: A systematic review. JAMA 2008; 299: 1698-1709.
31. Higginson IJ, Finlay IG, Goodwin DM, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manage 2003; 25: 150-168.
32. Bakitas M, Stevens M, Ahles T, et al. Project ENABLE: A palliative care demonstration project for advanced cancer patients in three settings. J Palliat Med 2004; 7: 363-372.
33. Temel JS, Jackson VA, Billings JA, et al. Phase II study: Integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol 2007; 25: 2377-2382.
34. Follwell M, Burman D, Le LW, et al. Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 2009; 27: 206-213.
35. Fadul N, Elsayem A, Palmer JL, et al. Supportive versus palliative care: What's in a name?: A survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer 2009; 115: 2013-2021.
36. Bakitas M, Lyons KD, Hegel MT, Ahles T. Oncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer center. Palliative & Supportive care 2013; 11: 415-23.
37. Morita T, Fujimoto K, Namba M, et al. Palliative care needs of cancer outpatients receiving chemotherapy: An audit of a clinical screening project. Support Care Cancer 2008; 16: 101-107.
38. Hamann HA, Lee JW, Schiller JH, et al. Clinician perceptions of care difficulty, quality of life, and symptom reports for lung cancer patients: An analysis from the Symptom Outcomes and Practice patterns (SOAPP) study. J Thorac Oncol 2013; 8: 1474-1483.
39. Le BH, Mileshkin L, Doan K, et al. Acceptability of early integration of palliative care in patients with incurable lung cancer. J Palliat Med 2014; 17: 553-558.
40. National Hospice and Palliative Care Organization. Physician Board Certification in Hospice and Palliative Medicine (HPM). Available at: Http://www.nhpco.org/palliative-care/physician-certification. Accessed November 19, 2014.
41. Parikh RB, Kirch RA, Smith TJ, Temel JS. Early specialty palliative care-Translating data in oncology into practice. N Engl J Med 2013; 369: 2347-2351.
42. Yoong J, Park ER, Greer JA, et al. Early palliative care in advanced lung cancer: A qualitative study. JAMA Intern Med 2013; 173: 283-290.
43. Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: Results of a randomized study of early palliative care. J Clin Oncol 2011; 29: 2319-2326.
44. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 2012; 30: 394-400.
45. Block SD, Billings JA. A need for scalable outpatient palliative care interventions. Lancet 2014; 383: 1699-1700.
46. Quill TE, Abernethy AP. Generalist plus specialist palliative care-creating a more sustainable model. N Engl J Med 2013; 368: 1173-1175.
47. Reyes-Gibby CC, Anderson KO, Shete S, et al. Early referral to supportive care specialists for symptom burden in lung cancer patients: A comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks. Cancer 2012; 118: 856-863.
48. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 2000; 320: 469-472.
49. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 2003; 327: 195-198.
50. Weissman DE, Meier DE. Identifying patients in need of a palliative care assessment in the hospital setting: A consensus report from the Center to Advance Palliative Care. J Palliat Med 2011; 14: 17-23.